Hot Pursuit     18-Dec-23
Zydus Lifesciences Ltd spurts 4%, up for fifth straight session
Zydus Lifesciences Ltd is quoting at Rs 671.75, up 4% on the day as on 12:44 IST on the NSE. The stock is up 64.14% in last one year as compared to a 16.44% jump in NIFTY and a 29.59% jump in the Nifty Pharma.

Zydus Lifesciences Ltd is up for a fifth straight session today. The stock is quoting at Rs 671.75, up 4% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is down around 0.03% on the day, quoting at 21449.3. The Sensex is at 71428.87, down 0.08%. Zydus Lifesciences Ltd has gained around 5.62% in last one month.

Meanwhile, Nifty Pharma index of which Zydus Lifesciences Ltd is a constituent, has gained around 3.68% in last one month and is currently quoting at 16179.8, up 1.29% on the day. The volume in the stock stood at 49.43 lakh shares today, compared to the daily average of 11.55 lakh shares in last one month.

The benchmark December futures contract for the stock is quoting at Rs 674.05, up 3.96% on the day. Zydus Lifesciences Ltd is up 64.14% in last one year as compared to a 16.44% jump in NIFTY and a 29.59% jump in the Nifty Pharma index.

The PE of the stock is 26.24 based on TTM earnings ending September 23.

Previous News
  Zydus Lifesciences Ltd gains for third straight session
 ( Hot Pursuit - 11-Sep-24   13:06 )
  Zydus partners with ICMR to initiate Phase 2 clinical trials of Desidustat oral tablet for treating sickle cell disease
 ( Corporate News - 15-Oct-24   10:08 )
  Zydus Lifesciences consolidated net profit rises 298.62% in the March 2024 quarter
 ( Results - Announcements 17-May-24   16:25 )
  Zydus Lifesciences Ltd leads losers in 'A' group
 ( Hot Pursuit - 16-Apr-25   15:00 )
  Zydus Lifesciences to hold board meeting
 ( Corporate News - 18-Jul-24   16:40 )
  Zydus Life gets tentative USFDA approval for Letermovir tablets
 ( Hot Pursuit - 23-Mar-24   14:21 )
  Zydus announces NDA acceptance of Desidustat in China by NMPA
 ( Corporate News - 23-Apr-24   16:06 )
  Zydus receives USFDA tentative approval for Letermovir tablets
 ( Corporate News - 23-Mar-24   14:00 )
  Zydus receives USFDA tentative approval for Edaravone Injection
 ( Corporate News - 14-Mar-24   13:51 )
  Zydus receives USFDA final approval for Chlorpromazine Hydrochloride Injection
 ( Corporate News - 14-Mar-24   12:24 )
  Zydus Lifesciences to hold board meeting
 ( Corporate News - 01-Nov-23   15:54 )
Other Stories
  GMR Airports' passenger traffic jumps 8% YoY in Mar'25
  21-Apr-25   10:19
  Divis Labs jumps on signing long-term manufacturing pact with global pharma major
  21-Apr-25   10:18
  Inox Wind soars as execution of 990 MW turnkey order accelerates in key Indian states
  21-Apr-25   10:18
  RailTel corp rallies on bagging Rs 20-cr order from UTI Infrastructure
  21-Apr-25   10:09
  Banking shares rise
  21-Apr-25   10:00
  HDFC AMC rallies after Q4 PAT jumps 18% YoY to Rs 639 cr; declares final dividend of Rs 90/sh
  21-Apr-25   09:57
  JB Chemicals & Pharma receives USFDA approval for Bisoprolol Tablets
  21-Apr-25   09:57
  Jio Financial Services Q4 PAT rises 2% YoY to Rs 316 cr
  21-Apr-25   09:55
  PSP Projects receives new order worth Rs 107.10 crore
  21-Apr-25   09:52
  BHEL records nearly 19% YoY growth in FY25 revenue; orderbook at Rs 1.95 lakh crore
  21-Apr-25   09:51
Back Top